The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K, Nomura T, Yamasaki M, Inoue T, Narimatsu T, Chisato Nakada PD, Yoshiyuki Tsukamoto PD, Matsuura K, Sato F, Moriyama M, Mimata H.
Hirai K, et al. Among authors: yamasaki m.
Urol Oncol. 2014 Feb;32(2):101-9. doi: 10.1016/j.urolonc.2012.09.005. Epub 2013 Feb 9.
Urol Oncol. 2014.
PMID: 23403204